New Dual-Action drug trial offers hope for hepatitis b patients
Disease control
Recruiting now
This study is testing whether azvudine tablets can provide long-term control of chronic hepatitis B. It will involve 120 participants who have not had prior antiviral treatment. Researchers will monitor virus levels, liver function, and immune response over 12 months to see if th…
Phase: PHASE3 • Sponsor: Zhigang Ren • Aim: Disease control
Last updated Mar 30, 2026 14:28 UTC